Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Rockefeller Capital Management L.P.
Rockefeller Capital Management L.P. trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 33.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,440 shares of the company’s stock after selling 2,697 shares during the period. Rockefeller Capital Management L.P.’s holdings in Henry Schein were worth $327,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of HSIC. Vanguard Group Inc boosted its position in Henry Schein by 0.6% in the 3rd quarter. Vanguard Group Inc now owns 16,264,736 shares of the company’s stock valued at $1,382,990,000 after buying an additional 89,166 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in Henry Schein by 19.8% during the 4th quarter. Janney Montgomery Scott LLC now owns 11,165 shares of the company’s stock worth $877,000 after buying an additional 1,844 shares during the period. Securian Asset Management Inc raised its stake in Henry Schein by 1.4% during the 4th quarter. Securian Asset Management Inc now owns 15,498 shares of the company’s stock worth $1,217,000 after buying an additional 221 shares during the period. Financial Gravity Companies Inc. acquired a new stake in shares of Henry Schein in the 4th quarter valued at about $29,000. Finally, Chicago Equity Partners LLC acquired a new stake in shares of Henry Schein in the 4th quarter valued at about $238,000.
A number of research firms recently issued reports on HSIC. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $78.00 target price on the stock in a research report on Monday, May 13th. Barrington Research boosted their price objective on Henry Schein from $72.00 to $75.00 and gave the stock an “outperform” rating in a report on Wednesday, May 8th. Leerink Swann cut Henry Schein from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $75.00 to $70.00 in a report on Wednesday, May 15th. They noted that the move was a valuation call. Svb Leerink reiterated a “market perform” rating and issued a $70.00 price target (down from $75.00) on shares of Henry Schein in a research report on Wednesday, May 15th. Finally, Craig Hallum reiterated a “buy” rating and issued a $77.00 price target (up from $72.00) on shares of Henry Schein in a research report on Wednesday, May 8th. Seven analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $74.27.
Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.76 by $0.04. The firm had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.36 billion. Henry Schein had a net margin of 4.10% and a return on equity of 18.35%. The company’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.95 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 3.45 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: “Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Rockefeller Capital Management L.P.” was originally posted by Marea Informative and is the property of of Marea Informative. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.mareainformativa.com/news/2019/06/12/henry-schein-inc-nasdaqhsic-shares-sold-by-rockefeller-capital-management-l-p.html.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: What is the QQQ ETF?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.